(firstQuint)Gemcitabine (GFF) in Patients With Pancreatic Cancer.

 This open-label, multi center phase II study was conducted to investigate the efficacy and safety of the combination of 5-Fluorouracil (5-FU)/folinic acid (FA) plus gemcitabine (GFF) in patients (pts) with advanced pancreatic cancer (APC).

 We consequently started this study after completing the phase I trial accomplished by our CONKO- study group.

.

 Gemcitabine (GFF) in Patients With Pancreatic Cancer@highlight

The purpose of this study is to examine the efficacy and safety of the drug combination GFF in patients with advanced pancreatic cancer (APC).

